Showing 76–86 of 86 international scientific journals (Biochemistry & Molecular Biology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 76 | Journal of Biological Inorganic Chemistry ISSN: 0949-8257 / 1432-1327 | 🇩🇪Germany | Q3 | CAS Tier 3 | 2.8 | 0.525Q2 | 96 | 74 | 0% | Springer Berlin Heidelberg | Profile |
| 77 | Luminescence ISSN: 1522-7235 / 1522-7243 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.8 | 0.399Q3 | 40 | 176 | 12.5% | John Wiley and Sons Ltd | Profile |
| 78 | Journal of Molecular Recognition ISSN: 0952-3499 / 1099-1352 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.7 | 0.478Q3 | 74 | 51 | 4.3% | John Wiley and Sons Ltd | Profile |
| 79 | Addiction Biology ISSN: 1369-1600 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.6 | 0.921Q1 | 70 | 141 | 3.2% | Wiley-Blackwell | Profile |
| 80 | Biochimica et Biophysica Acta-Bioenergetics ISSN: 0005-2728 / 1879-2650 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 2.6 | 0.943Q1 | 154 | 106 | 2.9% | Elsevier | Profile |
| 81 | Chromosome Research ISSN: 0967-3849 / 1573-6849 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 2.6 | 1.201Q2 | 75 | 25 | 0% | Springer Netherlands | Profile |
| 82 | DNA and Cell Biology ISSN: 1044-5498 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.6 | 0.664Q2 | 71 | 126 | 3.8% | Mary Ann Liebert Inc. | Profile |
| 83 | Journal of Membrane Biology ISSN: 0022-2631 / 1432-1424 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.6 | 0.87Q1 | 92 | 49 | 0% | Springer US | Profile |
| 84 | Mammalian Genome ISSN: 0938-8990 / 1432-1777 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.6 | 0.818Q2 | 92 | 78 | 7.4% | Springer US | Profile |
| 85 | Journal of Biomolecular Structure & Dynamics ISSN: 0739-1102 / 1538-0254 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.5 | 0.533Q2 | 58 | 770 | 18.5% | Taylor and Francis Ltd. | Profile |
| 86 | Journal of Food Biochemistry ISSN: 0145-8884 / 1745-4514 | 🇺🇸United States | Q4 | CAS Tier 2 | 2.3 | 0.859Q1 | 40 | 420 | 0% | Wiley-Blackwell | Profile |